Related Experiment Video
Updated: May 4, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Early microvascular changes with loss of the glycocalyx in children with type 1 diabetes
Claudia Nussbaum1, Ana Cavalcanti Fernandes Heringa1, Zuzana Mormanova1
1Division of Neonatology IS, Dr. von Hauner Children's Hospital, University Children's Hospital Munich, Munich, Germany.
Insights
Children with type 1 diabetes show early microvascular changes and glycocalyx loss, even without clinical signs of diabetic microangiopathy. These findings suggest the glycocalyx can help detect complications earlier.
Area of Science:
- Pediatric Endocrinology
- Vascular Biology
- Diabetes Research
Background:
- Type 1 diabetes mellitus (T1DM) can lead to microvascular complications.
- Early detection of diabetic microangiopathy is crucial for timely intervention.
- Subclinical microcirculatory changes may precede overt clinical manifestations.
Purpose of the Study:
- To investigate microcirculatory alterations and glycocalyx integrity in children with T1DM.
- To assess for subclinical signs of diabetic microangiopathy.
- To explore the potential of glycocalyx thickness as an early biomarker.
Main Methods:
- Sidestream dark field imaging of sublingual microcirculation in 14 children with T1DM and 14 controls.
- Analysis of vessel density, surface coverage, diameter distribution, flow index, and glycocalyx thickness.
- Statistical analysis using Wilcoxon rank sum test and Pearson correlation.
Main Results:
- Children with T1DM exhibited significantly reduced glycocalyx thickness (0.38 μm vs 0.60 μm) compared to controls.
- Glycocalyx thickness was inversely correlated with blood glucose levels (r = -0.55; P = .003).
- Increased percentage of larger vessels (>20 μm) and total vessel surface coverage was observed in children with T1DM.
Conclusions:
- Microvascular alterations and glycocalyx loss are detectable in children with T1DM before clinical diabetic microangiopathy.
- The glycocalyx serves as a potential monitoring measurement for early detection of diabetic microangiopathy.
- These findings may inform new therapeutic strategies for protecting or restoring the glycocalyx.
Objective:
To evaluate the microcirculation of children with type 1 diabetes mellitus who demonstrate no clinical signs of diabetic microangiopathy for the presence of microvascular alterations and glycocalyx perturbation.
Study Design:
Images of sublingual vessels were obtained in 14 children with diabetes (ages 12.8 ± 2.8 years, diabetes duration 6.7 ± 4.3 years) and 14 control patients (ages 11.8 ± 2.8 years) by the use of sidestream dark field imaging and analyzed for total vessel density, vessel surface coverage, vessel diameter distribution, mean flow index, and glycocalyx thickness. Wilcoxon rank sum test and Pearson correlation were used for statistical analysis.
Results:
We observed profound microcirculatory changes in children with diabetes compared with control patients, with a significant reduction of glycocalyx thickness (0.38 μm vs 0.60 μm; P = .013), which was inversely correlated with blood glucose levels (r = -0.55; P = .003). Furthermore, the percentage of large vessels (>20 μm diameter) was significantly increased (11% vs 6%; P = .023) at the expense of capillaries (<10 μm diameter) with consequent increase in total vessel surface coverage (30% vs 26.0%; P = .041). No differences were seen in total vessel density and mean flow index.
Conclusions:
Microvascular alterations, including changes in microvessel distribution and loss of the glycocalyx, can be detected in children with type 1 diabetes mellitus before clinically apparent vascular complications. Our results disclose the glycocalyx as a possible monitoring measurement for earlier detection of diabetic microangiopathy and may provide a basis for new therapeutic strategies aiming at protection or restoration of the glycocalyx.
Related Concept Videos
Diabetic Retinopathy
Type I Diabetes III: Clinical Manifestations
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetic Nephropathy
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

